Does the screening interval for Pap (Papanicolau) test with HPV (Human Papillomavirus) change for a 62-year-old patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cervical Cancer Screening at Age 62

For a 62-year-old patient, the screening interval for Pap with HPV co-testing remains every 5 years (or Pap alone every 3 years) until age 65, at which point screening can be discontinued only if there is adequate prior negative screening history. 1

Screening Recommendations for Ages 30-65

  • Women aged 30-65 years should receive cytologic and HPV co-testing every 5 years (preferred) or cytologic testing alone every 3 years (acceptable). 1
  • Your 62-year-old patient falls within this standard screening age range and should continue routine screening with the same intervals used for younger women in this age group. 1
  • The age of 62 does not trigger any change in screening frequency or methodology. 1

Critical Considerations for Discontinuing Screening at Age 65

Your patient's ability to exit screening at age 65 depends entirely on her prior screening history, not her current age of 62. 1

Requirements to Exit Screening at Age 65:

  • She must have 3 consecutive negative cytologic tests OR 2 consecutive negative co-tests within the past 10 years. 1
  • The most recent test must have been performed within the past 5 years. 1
  • She must have no history of high-grade squamous intraepithelial lesions (HSIL), adenocarcinoma in situ, or cancer. 1

Special Concerns for Women Over 60

  • Women over 60 with abnormal results (such as ASC-US with positive HPV) should NOT exit screening at age 65 without additional negative tests. 2, 3
  • The risk of cervical cancer is disproportionately high in women over 60 with abnormal screening results, even when dysplasia risk appears low. 2
  • If your patient has any recent abnormal results, she requires continued surveillance until obtaining 2 consecutive negative co-tests or 3 consecutive negative Pap tests before exiting screening. 2, 3

Common Pitfalls to Avoid

  • Do not prematurely discontinue screening at age 62 simply because the patient is approaching age 65. 1
  • Do not allow exit from screening at age 65 if the patient has had a recent abnormal result (such as HPV-positive ASC-US), as this is insufficient for safe exit. 2, 3
  • Do not assume that being over 60 years old automatically qualifies a patient to stop screening—the adequacy of prior negative screening history is what matters. 1

Algorithm for Your 62-Year-Old Patient

  1. Continue routine screening: Co-testing every 5 years or Pap alone every 3 years. 1
  2. Document screening history: Review whether she has adequate negative screening history (3 negative Paps or 2 negative co-tests in past 10 years, most recent within 5 years). 1
  3. Plan for age 65: If she meets exit criteria at age 65, screening can be discontinued; if not, continue screening beyond age 65 until criteria are met. 1
  4. If any abnormal results occur: Do not exit screening at age 65; continue surveillance until obtaining required consecutive negative tests. 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Abnormal Cervical Screening Results in Women Over 60

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of ASC-US with Atrophic Changes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended screening interval for a 34-year-old with a negative Pap test and no HPV testing, 3 years or 5 years?
What is the recommended management for a 41-year-old female with a PAP (Pap smear) result showing Atypical Squamous Cells of Undetermined Significance (ASCUS) and a Human Papillomavirus (HPV) negative status?
What is the recommended management for a 32-year-old patient with an abnormal Pap (Papanicolau) smear showing Atypical Squamous Cells of Undetermined Significance (ASCUS) and a negative Human Papillomavirus (HPV) test?
What is the next step for a 59-year-old female with a Pap result showing Atypical Squamous Cells of Undetermined Significance (ASC-US) and a negative Human Papillomavirus (HPV) test?
What is the next step for a patient with an Atypical Squamous Cells of Undetermined Significance (ASCUS) Pap smear result and a negative Human Papillomavirus (HPV) test?
What is a defecogram and how is it prepared for and managed post-procedure?
What is the prognosis and treatment for a patient with multiple renal cysts, including a 4cm simple cyst, microhematuria, and mildly elevated creatinine levels?
Should a patient with erythrocytosis on 200mg of testosterone every 2 weeks reduce the injection frequency to once a month?
What are the recommended diet and pharmacological weight loss options for a 28-year-old obese female?
Are Zosyn (piperacillin/tazobactam) and amikacin safe for patients with impaired renal function?
At what gestation week should the Glucose Challenge Test (GCT) be performed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.